Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Trauma (Emergency, Injury, Surgery)

Clinical Trials: Hemorrhage


A listing of clinical trials currently looking for volunteers to enroll in Hemorrhage studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : The University of Alabama at Birmingham

Aspirin in Reducing Events in the Elderly

Birmingham : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Birmingham : Cardio-Thoracic Surgeons, PC

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Birmingham : University of Alabama at Birmingham

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Birmingham :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Arizona

Phoenix : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Phoenix : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Phoenix : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Phoenix :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

California

Loma Linda : Loma Linda University Medical Center

Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery

Long Beach : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Long Beach : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Los Angeles : Cedars-Sinai Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Los Angeles : University of California Los Angeles

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

Los Angeles : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Los Angeles : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Los Angeles : University of Southern California, Keck School of Medicine

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Los Angeles : University of Southern California/Norris Comprehensive Cancer Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Los Angeles : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Orange : Vascular Interventional Specialists of Orange County

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Palo Alto : Stanford University Medical Center

Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery

Palo Alto : Stanford University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Pasadna : Lotus Clinical Research, LLC

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Sacramento : Mercy General Sacramento

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Sacramento : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Sacramento : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Sacramento : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Sacramento : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

San Francisco : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Torrance : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Torrance : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Colorado

Aurora : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Boulder : Boulder Neurological Institute

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Durango : Spine Colorado

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Connecticut

Hartford : Hartford Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

New Haven : Yale University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

District of Columbia

Washington : Georgetown University Hospital

Albumin for Intracerebral Hemorrhage Intervention

Washington : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Washington : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Washington :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Washington : Georgetown University

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

View More »

Washington DC : Georgetown University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Washington, DC : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Washington, DC : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Washington, DC : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Washington, DC : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Florida

Gainesville : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Gainsville : University of Florida Department of Aging and Geriatrics

Aspirin in Reducing Events in the Elderly

Jacksonville : Mayo Clinic, Jacksonville

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Jacksonville : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Jacksonville : Baptist Health Medical Center

The Evicel Post-Authorization Surveillance Study

View More »

Miami : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Miami : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Orlando : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Orlando : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Orlando : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Sarasota : Intercoastal Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Tampa : University of South Florida

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Tampa : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Tampa : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Tampa : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Georgia

Augusta : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Augusta : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Augusta : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Augusta : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Augusta : Novo Nordisk Clinical Trial Call Center

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

View More »

Austell : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Idaho

Boise : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Boise : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Illinois

Chicago : Rush Alzheimer's Disease Center

Aspirin in Reducing Events in the Elderly

Chicago : Rush University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Chicago : University of Chicago

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Chicago : University of Illinois at Chicago

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Chicago : Northwestern University

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

View More »

Oak Lawn : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Peoria : OSF Stroke Center

IV Double and Triple Concentrated Nicardipine for Stroke and ICH

Peoria : University of Illinois College of Medicine at Peoria

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Skokie : NorthShore University HealthSystem

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Springfield : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Springfield : Southern Illinois University School of Medicine

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Springfield :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Indiana

Carmel : Indiana Spine Group

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Indianapolis : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Indianapolis : Indiana Hemophilia and Thrombosis Center

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Iowa

Iowa City : University of Iowa

Aspirin in Reducing Events in the Elderly

Iowa City : University of Iowa

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Iowa City : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Iowa City : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Iowa City : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

View More »

Iowa City : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Iowa City :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Kentucky

Lexington : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Lexington : Bluegrass Orthopedics

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Lexington :

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

Lexington :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Louisville : Jewish Hospital

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.

Louisiana

New Orleans : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

New Orleans : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Maryland

Baltimore : Johns Hopkins University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Baltimore : University of Maryland

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Baltimore : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Baltimore : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Baltimore : Johns Hopkins University

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

View More »

Baltimore : University of Maryland Medical Systems

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

Baltimore : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Randallstown : Northwest Hospital

Intrauterine Use of FloSeal: Is it Safe and Useful?

Massachusetts

Boston : Massachusetts General Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Boston : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Boston : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Boston : Massachusetts General Hospital

Pilot Study of Model Based Iterative Reconstruction Using 64-Slice

Burlington : Lahey Clinic Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Michigan

Detroit : Wayne State University

Aspirin in Reducing Events in the Elderly

Detroit : Henry Ford Health System

Aspirin in Reducing Events in the Elderly

Detroit : Henry Ford Health System

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Detroit : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Detroit : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

View More »

Detroit : Wayne State University

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

Detroit : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Detroit : Henry Ford Hospital

Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

Detroit : Henry Ford Health System

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

East Lansing : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

East Lansing : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Kalamazoo : Borgess Research Institute

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Royal Oak : Beaumont Health System

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Minnesota

Minneapolis : Health Partners Research Foundation

Aspirin in Reducing Events in the Elderly

Minneapolis : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Minneapolis : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Minneapolis : Novo Nordisk Clinical Trial Call Center

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

St. Paul : Phalen Village Clinic

Aspirin in Reducing Events in the Elderly

Missouri

Springfield : Springfield Neurological and Spine Institute

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

St. Louis : St. Louis University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

St. Louis : Washington University School of Medicine

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Nebraska

Omaha : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Omaha : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Nevada

Las Vegas : William Muir MD Spine Surgery

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Las Vegas : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

New Jersey

Camden : Cooper University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Edison : New Jersey Neuroscience Institute at JFK

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

New Brunswick : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

New Brunswick : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

New Brunswick : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

View More »

Newark : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Newark : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Newark : Newark Beth Israel Medical Center

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Newark : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

New Mexico

Albuquerque : Lovelace Clinic Foundation

Aspirin in Reducing Events in the Elderly

New York

Brooklyn : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Buffalo : University of Buffalo

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Manhasset : Northshore University Hospital Long Island

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

New York : Columbia University Medical Center

Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage

New York : Columbia University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

New York : Mount Sinai Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

New York : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

New York : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

New York : Mt. Sinai Medical Center

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

New York : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

New York : Novo Nordisk Clinical Trial Call Center

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

New York City : New York-Presbyterian Hospital/Columbia University

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Rochester : The Mary M Gooley Hemophilia Center and Rochester General Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Rochester : Mary M Gooley Hemophilia Center

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Staten Island : Staten Island University Hosptial

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Syracuse : SUNY Upstate Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Syracuse : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Syracuse : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Valhalla : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Valhalla : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

North Carolina

Chapel Hill : University of North Carolina Chapel Hill

Aspirin in Reducing Events in the Elderly

Chapel Hill : The University of North Carolina at Chapel Hill

Lovaza's Effect on the Activation of Platelets

Chapel Hill : University of North Carolina at Chapel Hill

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Charlotte : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Durham : Duke University Hospital Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

View More »

Durham : Duke University Medical Center

Pilot Study of Model Based Iterative Reconstruction Using 64-Slice

Greensboro : Wake Forest University Baptist Medical Center

Aspirin in Reducing Events in the Elderly

Winston-Salem : Wake Forest University Baptist Medical Center

Aspirin in Reducing Events in the Elderly

Winston-Salem : Wake Forest School of Medicine

Aspirin in Reducing Events in the Elderly

Winston-Salem : Wake Forest University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Ohio

Cincinnati : University of Cincinnati

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Cincinnati : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Cincinnati : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Cincinnati : University of Cincinnati

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

Cincinnati : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

View More »

Cleveland : Case-Western Reserve University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Cleveland : Cleveland Clinic Foundation

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Cleveland : Cleveland Clinic Foundation

Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

Dayton : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Toledo :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Oklahoma

Tulsa : The University of Oklahoma - Tulsa

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Oregon

Portland : Providence Stroke Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Portland : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Portland : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Portland : Oregon Health & Science University Hospital & Clinics

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Portland : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Pennsylvania

Hershey : Penn State Hershey Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Monroeville :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Philadelphia : Temple University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Philadelphia : Albert Einstein Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Philadelphia : Thomas Jefferson University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

Philadelphia : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Philadelphia : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Philadelphia : Pennsylvania Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pittsburg :

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

Pittsburgh : University of Pittsburgh Health Sciences Research Center

Aspirin in Reducing Events in the Elderly

Pittsburgh : Allegheny General Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Pittsburgh : University of Pittsburgh Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Pittsburgh : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Pittsburgh : Hemophilia Center of Western Pennsylvania

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pittsburgh : UPMC-Presbyterian Hospital

Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures

Pittsburgh :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

South Carolina

Charleston : Medical University of South Carolina

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Charleston : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Charleston : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Charleston : Medical University of South Carolina

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

Charleston : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Tennessee

Memphis : Methodist Healthcare, University Hospital

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy

Nashville : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Nashville : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Nashville : Novo Nordisk Clinical Trial Call Center

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Texas

Dallas : University of Texas Southwestern Medical Center at Dallas

Aspirin in Reducing Events in the Elderly

Dallas : University of Texas, Southwestern, Dallas

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Fort Worth : University of North Texas Health Sciences Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Galveston : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Houston : University of Texas, Houston

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

Houston : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Houston : Novo Nordisk Clinical Trial Call Center

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Houston : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Houston : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Houston :

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

Houston : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Houston :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Houston : Novo Nordisk Clinical Trial Call Center

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Houston : Gulph States Hemophilia and Thrombophilia Center

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

McAllen : South Texas College

Aspirin in Reducing Events in the Elderly

McKinney :

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

San Antonio : UT Health Science Center at San Antonio

Aspirin in Reducing Events in the Elderly

San Antonio : University of Texas, San Antonio

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Utah

Salt Lake City : University of Utah

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Sandy : Physician's Research Options

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Virginia

Charlottesville : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Charlottesville : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Charlottesville : University of Virginia Health System Medical Center

Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

Norfolk : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Richmond : Virginia Commonwealth University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

Richmond : Virginia Commonwealth University

Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage

Washington

Bellevue : Nycomed Investigational Site

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery

Bellevue : Overlake Hospital Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Olympia : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Seattle : Swedish Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Seattle : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

View More »

Seattle : Virginia Mason Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Spokane : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Spokane : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Spokane : Northwest Orthopaedic Specialists, P.S.

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Tacoma : Multicare Neuroscience Center of Washington

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Wisconsin

Milwaukee : Children's Hospital of Wisconsin

Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

Milwaukee : Medical College of Wisconsin

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Milwaukee : Blood Center of Wisconsin

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Miwaukee : Froedtert Memorial Lutheran Hospital

Pilot Study of Model Based Iterative Reconstruction Using 64-Slice

Australia

Adelaide : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Adelaide : Royal Adelaide Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Parkville :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Perth : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Perth : Royal Perth Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Austria

Graz :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Vienna : Medical University Vienna

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Vienna : Allgemeines Krankenhaus der Stadt Wien - Universitätskliniken

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Belgium

Bonheiden :

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Brussells : Militair Hospitaal Koningin Astrid

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Brussels :

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Bruxelles : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Bruxelles : Cliniques Universitaires Saint-Luc

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

View More »

Bruxelles : Hopital Erasme, Service de Neurochirurgie

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Bruxelles : Clinique du Parc Leopold, Service de Neurochirurgie

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Flemish Brabant : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Gent : Universitair Ziekenhuis Gent, Gasto-Intestinale Heelkunde

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Leuven :

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Leuven : UZ Leuven

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Leuven : Universitair Ziekenhuis Leuven, Abdominale Heelkunde

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Brazil

Campinas :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Campinas :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Campinas Sao Paulo : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Bulgaria

Sofia : Specialized Haematological Hospital "Joan Pavel"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Sofia :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Varna : Multiprofile Hospital for Active Treatment "Sveta Marina"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Canada

Edmonton : University of Alberta

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Halifax : Queen Elizabeth II Health Sciences Centre

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Hamilton : Hamilton Health Science

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

London : London University Health Sciences Centre

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Montreal : Montreal Neurological Institute at McGill University

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

View More »

Montreal : McGill University Health Center

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Montreal : Royal Victoria Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Montreal : Jewish General Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Toronto :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Toronto : Toronto General Hospital

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Toronto : University of Toronto - St. Michael's Hospital

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Vancouver : St. Paul's Hospital

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Winnipeg : St. Boniface General Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

China

Beijing :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Beijing : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Changchun : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Changsha : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Chengdu : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

View More »

Chongqing : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Dalian : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Guangzhou : Guangzhou Southern Hospital

CavatermTM vs TCRE in Women With DUB

Guangzhou : Zhu Jiang Hospital

CavatermTM vs TCRE in Women With DUB

Hengyang : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Jinan : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Nanning : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Shanghai : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Shenyang : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Shijiazhuang : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Tianjin : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Wuhan : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Xi'an : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Croatia

Zagreb :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Zagreb :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Denmark

Århus N :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Copenhagen : Juliane Marie Centre, Rigshospitalet

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Herlev : University Hospital of Herlev

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Hilleroed : University Hospital of Hilleroed

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Hvidovre : University Hospital of Hvidovre

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Egypt

Cairo : Shoubra Maternity Hospital

Study About Patients Using Copper Intrauterine Device

Finland

Helsinki : HUCH Anaestesia and Surgery

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

France

Alencon : MEROUANI

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Amiens : LAIGLE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Annecy : SANTRE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Bordeaux : MOREL

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Bourg En Bresse : SEDILLOT

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

View More »

Brest : HIA Clermont-Tonnerre

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Brest : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Caen : BULEON

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Chambery : MIQUET

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Clamart : DEBIEN

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Clermont Ferrand : GUELON

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Clichy : PEASE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Creteil : COOK

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Dijon : NADJI

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

GAP : Vinsiniti

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Grenoble : DECLETY

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Kremlin-Bicêtre :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Kremlin-Bicêtre :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Le Kremlin Bicetre : Duranteau

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Lille : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Lille : GARRIGUE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Lyon :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Lyon : FLOCARD

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Marseille : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Marseille : GARCIN

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Metz : FAVIER

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Montpellier : CHARBIT

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Montpellier : YUNG

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Nancy : AUDIBERT

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Nantes : CHUPIN

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Nice : ICHAI

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Nimes : LEFRANT

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Paris : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Paris :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Paris : JOURNOIS

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Paris : LANGERON

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Paris : Mateo A Loris

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Pierre Benite : DAVID

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Poitiers : Nanadoumgar

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Reims : LEPOUSE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Rennes : Bleichner

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Rouen : GUITARD

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Saint Etienne : MARTIN

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Strasbourg : FREYS

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Toulon : MEAUDRE

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Toulouse : Service de neurologie

Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

Toulouse : OLIVIER

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Vannes : LEBAS

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Villefranche Sur Saone : JAULT

National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology

Germany

Bad Abbach : Department of Orthopedic Surgery

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Berlin :

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Berlin : Vivantes Klinikum im Friedrichshain

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Bonn :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Bonn : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

View More »

Bonn :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Duisburg : Gerinnungszentrum Rhein-Ruhr

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Erlangen : Department of Neurosurgery, University of Erlangen

Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)

Frankfurt am Main : Klinikum der J.-W.-Goethe-Universität

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Freiburg :

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Halle : University of Halle

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Hannover :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Hannover :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Heidelberg : University of Heidelberg

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Leipzig : University of Leipzig

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Mainz : University of Mainz

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Mainz : Universitätsmedizin der Johannes Gutenberg Universität Mainz

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

München : Technischen Universität München

A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue

Munich : Klinikum der Universität München

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Greece

Athens :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Hong Kong

Hong Kong : Prince of Wales Hospital

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Hong Kong : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Shatin, New Territories :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Hungary

Debrecen :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Debrecen :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

India

Karnataka : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Maharashtra : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Pune : Sahyadri Speciality Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pune : Jehangir Clinical Development Centre Pvt. Ltd.

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Pune : Sahyadri Specialty Hospital

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

View More »

Vellore : Christian Medical College

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Vellore : Christian Medical College

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Israel

Beer Sheva : OB\GYN Soroka University Medical Center

Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations

Haifa : Rambam Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Jerusalem : Hadassah Hebrew University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Ramat-Gan : Chaim Sheba Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Tel Aviv : Sourasky Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Italy

Bologna : Policlinico S. Orsola Malpighi

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Firenze :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Florence : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Florence : Azienda Ospedaliera Universitaria Careggi

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Milano :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

View More »

Milano :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Milano :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Milano : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Milano : Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Milano :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Milano : Fondazione Centro San Raffaele

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Milano : Granda Ospedale Maggiore Policlinico

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Roma : Università degli Studi di Roma "La Sapienza"

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Udine : Azienda Ospedaliera di Udine

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Vicenza : Ospedale San Bortolo

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Vicenza : ULSS6 Vicenza Ematologia

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Japan

Kasihara-City : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Kitakyushu : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Miyamae-ku : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Nagoya : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Shinjuku-ku : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

View More »

Shinjuku-ku, Tokyo :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Shinjuku-ku, Tokyo :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Shinjuku-ku, Tokyo :

Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725

Suginami-ku : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Suginami-ku, Tokyo :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Suginami-ku, Tokyo :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Tokyo : Tokyo Medical University Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Korea, Republic of

Ansan : Korea University Ansan Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Anyang : Hallym University Sacred Heart Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Bucheon : Soonchunhyang University Bucheon Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Busan : Pusan National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Busan : Dong-A University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

View More »

Busan : Inje Univercity Heaundae Paik Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Busan : Inje University Pusan Paik Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Busan : Kosin University Gospel Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Changwon : Samsung changwon Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Changwon : Chang Won Fatima hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Cheonan : Soonchunhyang University Cheonan Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Cheongju : Chungbuk National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Chuncheon : Kangwon National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Daegu : Keimyung University Dongsan Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Daegu : Daegu Fatima Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Daejeon :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Daejeon :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Daejon : Eulji University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deagu : Kyungpook National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deagu : Yeungnam University Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deagu : Dongsan Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deagu : Deagu Catholic University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deajeon : Deajeon St.Mary's Hospital, The Catholic University of Korea

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Deajeon : Chungnam National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Goyang : Inje University Ilsan Paik Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Goyang : Dongguk University International Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Goyang-si : National Health Insurance Corporation Ilsan Hoapital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Guri : Hanyang University Guri Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

GwangJu : Chosun University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Gwangju : Chonnam National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Iksan : Wonkwang University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Incheon : Gachon University Gil Hoapital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Inchon : Inha University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Jeonju-si : Chonbuk National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Jinju : Gyeongsang National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Pusan : Wallace Memorial Baptist Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seongnam : Seoul National University Bundang Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seongnam-si : Bundang Medical Center, CHA University

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Gangnam Severance Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Kangdong Sacred Heart Hospital, Hallym University

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Ewha Womans University Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : National Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Seoul National University Borame Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Konkuk Univ. Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Asan Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Seoul Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Seoul National University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Seoul St.Mary's Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Severance Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Soonchunhyang University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : St. Mary's Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Chung-Ang University Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Eulji Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Hangang Sacred Heart Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Hanyang University Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Inje University Sanggye Paik Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Kangbuk Samsung Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Kangnam Sacred Heart Hospital, Hallym University College of Medicine

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Korea University Anam Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Korea University Guro Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Seoul : Kyung Hee University Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Suwon : Ajou University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Uijeongbu : Uijeongbu St. Mary's Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Ulsan : Ulsan University Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Wonju : Wonju Christian Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Latvia

Riga :

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Macedonia, The Former Yugoslav Republic of

Skopje :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Skopje :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Malaysia

Kuala Lumpur :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Kuala Lumpur :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Kuala Lumpur :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Selangor Darul Ehsan :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Netherlands

Breda : Amphia Hospital

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Enschede : Medisch Spectrum Twente

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Groningen :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Groningen :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Groningen : University Medical Centre Groningen

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

View More »

Leiden : Leiden University Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Nijmegen : Radboud University Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Rotterdam : Erasmus MC

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Rotterdam : Erasmus Medical Center

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Utrecht :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Utrecht :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Velp : Rijnstate Arnhem

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Norway

Oslo :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Oslo :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Pakistan

Karachi, Sindh : Site Reference ID/Investigator# 77680 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Karachi, Sindh : Site Reference ID/Investigator# 77681 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Karachi, Sindh : Site Reference ID/Investigator# 77674 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Karachi, Sindh : Site Reference ID/Investigator# 77675 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Karachi, Sindh : Site Reference ID/Investigator# 77677 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

View More »

Lahore, Punjab : Site Reference ID/Investigator# 77691 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Lahore, Punjab : Site Reference ID/Investigator# 77695 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Lahore, Punjab : Site Reference ID/Investigator# 77696 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Lahore, Punjab : Site Reference ID/Investigator# 77699 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Multan, Punjab : Site Reference ID/Investigator# 77684 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Multan, Punjab : Site Reference ID/Investigator# 77686 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Multan, Punjab : Site Reference ID/Investigator# 77687 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Multan, Punjab : Site Reference ID/Investigator# 77689 Updated

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Panama

Pittsburgh : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Philippines

Manila : University of Santo Tomas

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Manila : Manila Doctors Hospital

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Pasig : The Medical City

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Quezon City : St. Luke's Medical Center

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Poland

Gdansk : Uniweryteckie Centrum Kliniczne

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Lodz : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Warsaw : Institute of Haematology and Transfusion Medicine

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Puerto Rico

San Juan : Puerto Rico Medical Center

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

San Juan : Novo Nordisk Clinical Trial Call Center

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

San Juan : Novo Nordisk Clinical Trial Call Center

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

San Juan : Novo Nordisk Clinical Trial Call Center

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Russian Federation

Irkutsk : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Krasnodar : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Saint-Petersburg :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Saint-Petersburg :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Saint-Petersburg :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

South Africa

Cape Town : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Johannesburg : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Johannesburg : Hemophilia Comprehensive Care Center

Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery

Parktown Johannesburg :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Parktown Johannesburg :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Spain

Barcelona : Vall d'Hebron University Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Barcelona : Bellvitge Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Barcelona : Hospital de la Santa Creu i Sant Pau

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Barcelona : Hospital Clinic i Provincial

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Barcelona : Hospital de Sabadell

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

View More »

Getafe : Hospital Universitario de Getafe

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Madrid :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Madrid :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Madrid :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Madrid :

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Madrid :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Madrid :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Palma de Mallorca : Hospital Son Dureta

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Pamplona : Clinica Universitaria de Navarra

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Santander : Hospital Universitario Marques de Valdecilla

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Sweden

Gothenburg : Sahlgrenska Universitetssjukhuset

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

Malmö :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Malmö :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Malmö : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Malmoe : Skåne University Hospital (SUS)

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

View More »

Stockholm : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Switzerland

Zurich : University of Zurich

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Zürich :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Zürich :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Taiwan

Taipei :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Taipei :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Taipei :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Taipei :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Taipei :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

View More »

Taipei : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Thailand

Bangkok :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Bangkok : Updated

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Turkey

Adana :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Bornova-IZMIR :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

Bornova-IZMIR :

Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Kayseri :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Konya :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

View More »

Konya :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

United Kingdom

Birmingham : Queen Elizabeth Hospital Birmingham

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Cambridge : Addenbrookes Hospital Vascular Department

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Cambridge : Papworth Hospital

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Cambridgeshire : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

Cardiff :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

View More »

Doncaster : Doncaster Royal Infirmary

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Doncaster : Doncaster Royal Infirmary Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Edgbaston : Queen Elizabeth Hospital Birmingham

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Edinburgh : Royal Infirmary of Edinburgh

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Epsom : South West London Elective Orthopaedic Center

Bipolar Sealer Aquamantys Use in Total Knee Replacement

Frimley : Frimley Park Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Hull : Hull Royal Infirmary

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Hull : Hull Royal Infirmary

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Leeds : Leeds General Infirmary

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Leeds : Leeds General Infirmary

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

London :

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

London :

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A

London :

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

London : Research Site

Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B

London : Hammersmith Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

London : Royal Free Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

London : The Royal London Hospital

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

London : King's College Hospital

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

London : King's College Hospital NHS Foundation Trust

Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:

London :

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Newcastle upon Tyne : Newcastle General Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Newcastle upon Tyne : Freeman Hospital

Phase 3 Study of Fibrocaps™ in Surgical Bleeding

Newcastle upon Tyne : Freeman Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Oxford :

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

Southampton : University of Southampton Hospital

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Southampton : Southampton General Hospital

Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery

Tooting : St. George's Hospital

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

Vietnam

Danang : Research Site

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

Hanoi : Research Site

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

HoChiMinh City : Research Site

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients